Literature DB >> 28464477

Smoking Behavior Changes in the Early Rheumatoid Arthritis Period and Risk of Mortality During Thirty-Six Years of Prospective Followup.

Jeffrey A Sparks1, Shun-Chiao Chang1, Uyen-Sa D T Nguyen2, Medha Barbhaiya1, Sara K Tedeschi1, Bing Lu1, Karen H Costenbader1, Yuqing Zhang3, Hyon K Choi4, Elizabeth W Karlson1.   

Abstract

OBJECTIVE: To investigate whether rheumatoid arthritis (RA) diagnosis influences smoking behavior changes and whether these changes were associated with mortality.
METHODS: We identified an incident RA cohort in the Nurses' Health Study (NHS; 1976-2012). Behavioral data were collected through biennial questionnaires. We created a comparison cohort, matching RA cases to women without RA by age and calendar year at the index date of RA diagnosis. To investigate smoking behavior changes in the early RA period, sustained cessation was defined as permanently quitting within 4 years of the RA/index date. We used Cox regression to obtain hazard ratios (HRs) for mortality, comparing sustained smoking cessation to continued smoking.
RESULTS: Among 121,700 women in the NHS, we identified 938 with incident RA matched to 8,951 non-RA comparators. Among current smokers, 40.0% with RA permanently quit smoking in the early RA period, compared to 36.1% of comparators (odds ratio for sustained cessation 1.18 [95% confidence interval (95% CI) 0.88, 1.58]). There were 313 deaths (33.4%) in the RA cohort and 2,042 (22.8%) among comparators. Compared to continued smoking, sustained cessation was associated with similarly decreased mortality in both the RA (HR 0.58 [95% CI 0.33, 1.01]) and comparison (HR 0.47 [95% CI 0.39, 0.58]) cohorts. Women with RA had higher mortality for >5 post-RA pack-years (HR 3.67 [95% CI 2.80, 4.81]) than comparators with >5 post-index pack-years (HR 1.88 [95% CI 1.62, 2.17]; P < 0.001 for interaction; reference: ever-smoker non-RA women with 0 post-index pack-years).
CONCLUSION: Sustained smoking cessation within 4 years of RA diagnosis reduced mortality risk, with a similar effect observed among non-RA comparators. Smoking >5 pack-years after RA diagnosis significantly increased mortality beyond the risk of non-RA comparators.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Year:  2017        PMID: 28464477      PMCID: PMC5668209          DOI: 10.1002/acr.23269

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  41 in total

1.  Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity.

Authors:  J C Chehata; A B Hassell; S A Clarke; D L Mattey; M A Jones; P W Jones; P T Dawes
Journal:  Rheumatology (Oxford)       Date:  2001-04       Impact factor: 7.580

2.  Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis.

Authors:  Kwangwoo Kim; Xia Jiang; Jing Cui; Bing Lu; Karen H Costenbader; Jeffrey A Sparks; So-Young Bang; Hye-Soon Lee; Yukinori Okada; Soumya Raychaudhuri; Lars Alfredsson; Sang-Cheol Bae; Lars Klareskog; Elizabeth W Karlson
Journal:  Arthritis Rheumatol       Date:  2015-10       Impact factor: 10.995

3.  Effect of Smoking on Remission Proportions Differs Between Male and Female Patients with Rheumatoid Arthritis: A Study Based on the IORRA Survey.

Authors:  Yasushi Inoue; Ayako Nakajima; Eiichi Tanaka; Eisuke Inoue; Akiko Kobayashi; Daisuke Hoshi; Naoki Sugimoto; Yohei Seto; Atsuo Taniguchi; Shigeki Momohara; Hisashi Yamanaka
Journal:  J Rheumatol       Date:  2015-03-15       Impact factor: 4.666

Review 4.  Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.

Authors:  D Sugiyama; K Nishimura; K Tamaki; G Tsuji; T Nakazawa; A Morinobu; S Kumagai
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

5.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

6.  Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Simin Liu; Christine G Parks; Nicole C Wright; Larry W Moreland
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

7.  Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.

Authors:  José Félix Restrepo; Inmaculada del Rincón; Daniel F Battafarano; Roy W Haas; Merced Doria; Agustín Escalante
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

8.  The widening mortality gap between rheumatoid arthritis patients and the general population.

Authors:  Angel Gonzalez; Hilal Maradit Kremers; Cynthia S Crowson; Paulo J Nicola; John M Davis; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2007-11

9.  Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis.

Authors:  E W Karlson; S-C Chang; J Cui; L B Chibnik; P A Fraser; I De Vivo; K H Costenbader
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Smoking and overweight determine the likelihood of developing rheumatoid arthritis.

Authors:  Maria J H de Hair; Robert B M Landewé; Marleen G H van de Sande; Dirkjan van Schaardenburg; Lisa G M van Baarsen; Danielle M Gerlag; Paul P Tak
Journal:  Ann Rheum Dis       Date:  2012-10-27       Impact factor: 19.103

View more
  8 in total

Review 1.  Obstructive lung diseases and risk of rheumatoid arthritis.

Authors:  H Maura Friedlander; Julia A Ford; Alessandra Zaccardelli; Alexsandra V Terrio; Michael H Cho; Jeffrey A Sparks
Journal:  Expert Rev Clin Immunol       Date:  2020-01-06       Impact factor: 4.473

2.  Impact of secondhand smoking on disease activity in women with rheumatoid arthritis.

Authors:  Nevin Hammam; Tamer A Gheita
Journal:  Clin Rheumatol       Date:  2017-08-25       Impact factor: 2.980

Review 3.  Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.

Authors:  Emily K Wu; Robert D Ambrosini; R Matthew Kottmann; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Curr Rheumatol Rev       Date:  2019

4.  Smoking Cessation Rates among Patients with Rheumatoid Arthritis and Osteoarthritis Following the 'Gold Standard Programme' (GSP): A Prospective Analysis from the Danish Smoking Cessation Database.

Authors:  Monika Laugesen; Mette Rasmussen; Robin Christensen; Hanne Tønnesen; Henning Bliddal
Journal:  Int J Environ Res Public Health       Date:  2022-05-10       Impact factor: 4.614

5.  Weight Change During the Early Rheumatoid Arthritis Period and Risk of Subsequent Mortality in Women With Rheumatoid Arthritis and Matched Comparators.

Authors:  Jeffrey A Sparks; Shun-Chiao Chang; Uyen-Sa Nguyen; Medha Barbhaiya; Sara K Tedeschi; Bing Lu; David J Kreps; Karen H Costenbader; Yuqing Zhang; Hyon K Choi; Elizabeth W Karlson
Journal:  Arthritis Rheumatol       Date:  2017-12-07       Impact factor: 10.995

6.  Predictors of Smoking Cessation in Patients With Rheumatoid Arthritis in Two Cohorts: Most Predictive Health Care Factors.

Authors:  Maria Schletzbaum; Xing Wang; Robert Greenlee; Megan E Piper; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-05       Impact factor: 4.794

7.  Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.

Authors:  Ida K Roelsgaard; Bente A Esbensen; Mikkel Østergaard; Silvia Rollefstad; Anne G Semb; Robin Christensen; Thordis Thomsen
Journal:  Cochrane Database Syst Rev       Date:  2019-09-02

8.  Smoking Behaviour Changes After Diagnosis of Inflammatory Bowel Disease and Risk of All-cause Mortality.

Authors:  Xinwei Hua; Emily W Lopes; Kristin E Burke; Ashwin N Ananthakrishnan; James M Richter; Chun-Han Lo; Paul Lochhead; Andrew T Chan; Hamed Khalili
Journal:  J Crohns Colitis       Date:  2022-08-04       Impact factor: 10.020

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.